I will ask members and the witnesses to take their seats, please.
I apologize. We are starting a couple of minutes late. We were delayed at the last tour we had today.
Pursuant to Standing Order 108(2), this is the 40th meeting of the Standing Committee on Industry, Science and Technology. This is the western part of the national tour we're doing with respect to our study on science and technology across Canada.
We had a very good session this morning, with some very interesting tours and discussions about science and technology policy.
We have two panels this afternoon. The first panel is running for an hour and 15 minutes. It's a very short time period, but we have to catch a flight to Saskatoon tonight.
The first panel is composed of three organizations. First of all, from the National Research Council of Canada, we have the director general, Mr. Ian Smith, with the Institute for Biodiagnostics; secondly, we have the vice-president of life sciences, Mr. Roman Szumski.
From the second organization, the University of Manitoba, from TRLabs Manitoba operations, we have the director, Len Dacombe. The third organization is the Winnipeg Regional Health Authority, and we have Mr. Harry Schulz, the chief innovation officer for the Health Sciences Centre.
Welcome to all of you, gentlemen.
We have five minutes for each organization, and then we will go to questions from members. I believe we'll be starting with Mr. Smith.
You can begin at any time, Mr. Smith.